EIM
ABMD

Essex Investment Management’s Abiomed Inc ABMD Stock Holding History

Essex Investment Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-3,918
Closed -$504K – 385
2016
Q3 		$504K Hold
3,918
– – 0.08% 255
2016
Q2 		$428K Buy
+3,918
New +$390K 0.07% 255
2014
Q2 		– Sell
-30,000
Closed -$781K – 375
2014
Q1 		$781K Buy
+30,000
New +$830K 0.11% 212

Other funds holding ABMD

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Essex Investment Management's ABMD Position: Q4 2016 in Review

Essex Investment Management sold out of Abiomed Inc (ABMD) in Q4 2016, closing a stake of 3,918 shares — an estimated $504K sold.

Essex Investment Management first reported a position in ABMD in Q1 2014 and held it in 3 quarters. The position peaked at $781K in Q1 2014. 297 funds tracked by Wall St. Rank hold ABMD as of Q4 2016.

  • Essex Investment Management reported no remaining Abiomed Inc position as of Q4 2016 after selling out during the quarter.
  • Essex Investment Management sold 3,918 Abiomed Inc shares in Q4 2016, an estimated $504K.
  • Essex Investment Management first reported a position in Abiomed Inc in Q1 2014 and held it in 3 quarters.
  • Essex Investment Management's Abiomed Inc position peaked at $781K in Q1 2014.
  • 297 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2016.

Based on Essex Investment Management's 13F filing for Q4 2016, filed 8 Feb 2017.